BI Asset Management Fondsmaeglerselskab A S raised its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 18.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 192,144 shares of the company's stock after purchasing an additional 29,363 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S's holdings in Nutrien were worth $9,544,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in Nutrien by 7.1% in the first quarter. Vanguard Group Inc. now owns 21,191,003 shares of the company's stock worth $1,051,709,000 after purchasing an additional 1,412,503 shares in the last quarter. Mackenzie Financial Corp lifted its holdings in Nutrien by 0.7% in the first quarter. Mackenzie Financial Corp now owns 7,855,609 shares of the company's stock valued at $389,860,000 after acquiring an additional 54,918 shares during the period. Deutsche Bank AG lifted its holdings in Nutrien by 6.5% in the first quarter. Deutsche Bank AG now owns 7,568,805 shares of the company's stock valued at $375,943,000 after acquiring an additional 463,748 shares during the period. JPMorgan Chase & Co. lifted its holdings in Nutrien by 48.7% in the first quarter. JPMorgan Chase & Co. now owns 6,992,535 shares of the company's stock valued at $347,319,000 after acquiring an additional 2,291,518 shares during the period. Finally, ARGA Investment Management LP raised its stake in shares of Nutrien by 7.7% during the 1st quarter. ARGA Investment Management LP now owns 6,510,844 shares of the company's stock worth $323,132,000 after buying an additional 467,254 shares during the period. Hedge funds and other institutional investors own 63.10% of the company's stock.
Nutrien Price Performance
Shares of NTR traded up $0.0690 during trading hours on Monday, reaching $57.9690. 1,444,708 shares of the company traded hands, compared to its average volume of 2,250,151. The stock has a market capitalization of $28.18 billion, a PE ratio of 20.77, a price-to-earnings-growth ratio of 0.98 and a beta of 0.81. The stock has a fifty day simple moving average of $59.21 and a 200 day simple moving average of $55.73. Nutrien Ltd. has a fifty-two week low of $43.69 and a fifty-two week high of $65.08. The company has a quick ratio of 0.85, a current ratio of 1.33 and a debt-to-equity ratio of 0.39.
Nutrien (NYSE:NTR - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported $2.65 earnings per share for the quarter, topping the consensus estimate of $2.41 by $0.24. The company had revenue of $10.30 billion during the quarter, compared to the consensus estimate of $10.40 billion. Nutrien had a return on equity of 6.51% and a net margin of 5.25%.The company's revenue was up 2.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.34 earnings per share. As a group, research analysts predict that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.
Nutrien Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 17th. Investors of record on Monday, September 29th will be given a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 3.8%. The ex-dividend date is Monday, September 29th. Nutrien's dividend payout ratio (DPR) is currently 78.14%.
Analysts Set New Price Targets
NTR has been the subject of several research reports. UBS Group dropped their price target on Nutrien from $64.00 to $63.00 and set a "neutral" rating for the company in a research report on Thursday, August 7th. Raymond James Financial cut Nutrien from an "outperform" rating to a "market perform" rating and set a $68.00 price target for the company. in a report on Tuesday, June 17th. Wall Street Zen raised Nutrien from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 9th. Barclays increased their target price on Nutrien from $61.00 to $64.00 and gave the stock an "equal weight" rating in a research note on Monday, July 7th. Finally, Zacks Research raised Nutrien from a "hold" rating to a "strong-buy" rating in a research report on Monday, August 18th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Nutrien currently has an average rating of "Moderate Buy" and an average target price of $62.65.
Read Our Latest Analysis on NTR
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
See Also

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.